ALCEDIAG is the maker of EDITOX, a cellular test evaluating the risk of a molecule of causing psychiatric side effects in humans, in particular depression and suicide.
EDITOX is primarily intended for use by pharmaceutical companies during preclinical development phases to anticipate the potential psychiatric side effects in a drug candidate.
EDITOX is an effective, economically advantageous and ethical alternative to the tests currently conducted on rodents.
Predictive Tests of the Psychiatric Side Effects of Medication – EDITOX - ALCEDIAG
